Lying in wait at the moment are well-entrenched therapies like Novartis' Xiidra (lifitegrast) and AbbVie's Restasis (cyclosporine), which are not considered to be particularly effective and have ...

But with Novartis failing to convince European regulators about the merits of Xiidra last year, and Allergan's ageing Restasis potentially facing generic competition, there’s a lot to play for ...

Julie Bowen is teaming up with Xiidra to raise awareness about dry eye relief. Keep an eye out for more from Julie and Xiidra! 👁️💧 To see more, follow us on FAB’s Instagram ...

It was a strange way to complete a first.

The lack of methods for preparing miniature lasers directly on silicon wafers is holding back photonic technology in a range of applications, including machine learning. The solution could be to ...